Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human Immunodeficiency Virus Seroconversion Among Men Who Have Sex With Men Who Use Event-Driven or Daily Oral Pre-Exposure Prophylaxis (CohMSM-PrEP): A Multi-Country Demonstration Study From West Africa.
Laurent C, Yaya I, Cuer B, Sagaon-Teyssier L, Mensah E, Dah TTE, Coulibaly A, Kouamé MJ, Peytavin G, Serrano L, Eubanks A, Traoré I, Diallo F, Riegel L, Rojas Castro D, Dagnra CA, Anoma C, Vuylsteke B, Dembélé Keita B, Spire B; CohMSM-PrEP Study Group. Laurent C, et al. Among authors: peytavin g. Clin Infect Dis. 2023 Aug 22;77(4):606-614. doi: 10.1093/cid/ciad221. Clin Infect Dis. 2023. PMID: 37052469
Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial.
Le Turnier P, Charreau I, Gabassi A, Carette D, Cotte L, Pialoux G, Tremblay C, Spire B, Chaix ML, Meyer L, Capitant C, Delaugerre C, Raffi F, Molina JM; ANRS IPERGAY study group. Le Turnier P, et al. Sex Transm Infect. 2023 Mar;99(2):140-142. doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8. Sex Transm Infect. 2023. PMID: 36601747 Clinical Trial.
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
Bachelard A, Isernia V, Charpentier C, Benalycherif A, Mora M, Donadille C, Duvivier C, Lacombe K, El Mouhebb M, Spire B, Landman R, Descamps D, Peytavin G, Assoumou L, Ghosn J; FAST study group. Bachelard A, et al. Among authors: peytavin g. J Antimicrob Chemother. 2023 Mar 2;78(3):769-778. doi: 10.1093/jac/dkad008. J Antimicrob Chemother. 2023. PMID: 36659824
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH).
Marcellin F, Brégigeon-Ronot S, Ramier C, Protopopescu C, Gilbert C, Di Beo V, Duvivier C, Bureau-Stoltmann M, Rosenthal E, Wittkop L, Salmon-Céron D, Carrieri P, Sogni P, Barré T; ANRS CO13 HEPAVIH Study Group; Scientific Committee; Clinical Centers (ward: participating physicians); Data collection; Management, statistical analyses. Marcellin F, et al. JHEP Rep. 2022 Oct 28;5(1):100614. doi: 10.1016/j.jhepr.2022.100614. eCollection 2023 Jan. JHEP Rep. 2022. PMID: 36466990 Free PMC article.
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
Mandelbrot L, Tubiana R, Frange P, Peytavin G, Le Chenadec J, Canestri A, Morlat P, Brunet-Cartier C, Sibiude J, Peretti D, Chambrin V, Chabrol A, Bui E, Simon-Toulza C, Marchand L, Paul C, Delmas S, Avettand-Fenoel V, Warszawski J; Monogest study group. Mandelbrot L, et al. Among authors: peytavin g. J Antimicrob Chemother. 2023 Jul 5;78(7):1711-1722. doi: 10.1093/jac/dkad161. J Antimicrob Chemother. 2023. PMID: 37248782 Free PMC article. Clinical Trial.
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, Tisserand P, Surenaud M, Coléon S, Prague M, Guillaumat L, Krief C, Fenwick C, Laouénan C, Bouadma L, Ghosn J, Pantaleo G, Thiébaut R; French COVID cohort study group; Lévy Y. Hocini H, et al. J Clin Immunol. 2023 Jul;43(5):882-893. doi: 10.1007/s10875-023-01459-x. Epub 2023 Mar 21. J Clin Immunol. 2023. PMID: 36943669 Free PMC article.
Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen--ANRS 111 trial.
Duval X, Mentré F, Rey E, Auleley S, Peytavin G, Biour M, Métro A, Goujard C, Taburet AM, Lascoux C, Panhard X, Tréluyer JM, Salmon-Céron D; Cophar 2 Study Group. Duval X, et al. Among authors: peytavin g. Fundam Clin Pharmacol. 2009 Aug;23(4):491-500. doi: 10.1111/j.1472-8206.2009.00693.x. Fundam Clin Pharmacol. 2009. PMID: 19709326 Free PMC article. Clinical Trial.
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.
Bachelard A, Le Hingrat Q, Ferré VM, Lê M, Peytavin G, Damond F, Charpentier C, Fremont Goudot G, Goupil de Bouille J, Lariven S, Delobel P, Yazdanpanah Y, Descamps D, Matheron S, Ghosn J; ANRS CO05 VIH-2 cohort study group. Bachelard A, et al. Among authors: peytavin g. Clin Infect Dis. 2024 Apr 10;78(4):1005-1010. doi: 10.1093/cid/ciad695. Clin Infect Dis. 2024. PMID: 38630945
483 results